Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and hematological responses to hydroxyurea in Sicilian patients with Hb S/beta-thalassemia.

Hemoglobin - 1 Feb 2001

Rigano P, Rodgers G P, Renda D, Renda M C, Aquino A, Maggio A

Abstract excerpt

Although, several reports have detailed that hydroxyurea can ameliorate the clinical course of adult and pediatric patients with sickle cell anemia (Hb S or beta(S)), few clinical studies have been carried out in patients with beta(S)/beta-thalassemia. In a two-year clinical study, we evaluated the efficacy of hydroxyurea in a group of 22 adult Sicilian patients with beta(S)/beta-thalassemia with severe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Cell Count
Share to Bone Marrow Diseases
Share to Hospitalization

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hydroxyurea

Share to Sicily

Share to Sickle Cell Trait

Share to Thalassemia

Share to Treatment Outcome

Source

Identifiers

PMID: 11300353
DOI: 10.1081/hem-100103065

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and hematological responses to hydroxyurea in Sicilian patients with Hb S/beta-thalassemia.PMID 11300353Read ↗

Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.Semantic proximity Read ↗

Effects of hydroxyurea treatment for patients with hemoglobin SC diseaseSemantic proximity Read ↗

Clinical, hematological, and molecular features in Sicilians with Hb S-beta-thalassemia.Semantic proximity Read ↗

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.Semantic proximity Read ↗

Low and fixed dose of hydroxyurea is effective and safe in patients with HbSβ(+) thalassemia with IVS1-5(G→C) mutation.Semantic proximity Read ↗

Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia.Semantic proximity Read ↗

Fetal Hemoglobin and F-Cell Responses to Long-Term Hydroxyurea Treatment in Young Sickle Cell PatientsSemantic proximity Read ↗

A mild type of Hb S-beta(+)-thalassemia [-92(C-->T)] in a Sicilian family.Semantic proximity Read ↗

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.Semantic proximity Read ↗

Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.Semantic proximity Read ↗

Hydroxyurea Therapy in ThalassemiaaSemantic proximity Read ↗

Molecular identification of Sicilian (deltabeta) degrees-thalassemia associated with beta-thalassemia and hemoglobin S in Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.